Trials / Completed
CompletedNCT00932074
A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
A Phase 1/2 Study Evaluating the Safety, Tolerability and Efficacy of KP-413 Topical Ointment in Subjects With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Kaken Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety, tolerability and efficacy of KP-413 topical ointment compared with vehicle ointment in treating adult subjects with atopic dermatitis (AD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KP-413 Ointment | Study drug ointment to be applied topically to the selected treatment areas on the head/neck and torso/limbs twice a day for 4 weeks. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2009-07-02
- Last updated
- 2012-04-06
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00932074. Inclusion in this directory is not an endorsement.